• Poster

Cost-Effectiveness of Pegaptanib in Age-Related Macular Degeneration: The Impact of Differences Between USA and UK Health Care Systems

Citation

Javitt, J. C., Wolowacz, S. E., Roskell, N. S., Maciver, F., Kelly, S., Pleil, A. M., & Zlateva, G. P. (2006, October). Cost-Effectiveness of Pegaptanib in Age-Related Macular Degeneration: The Impact of Differences Between USA and UK Health Care Systems. Presented at ISPOR 9th Annual European Congress, .

Abstract